Skip Navigation

Table of Contents

Volume 14 Issue 5 May 2012

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

Cover/Standing Material

  • Cover Page

    Neuro Oncol (2012) 14(5): NP doi:10.1093/neuonc/nos030

  • Editorial Board

    Neuro Oncol (2012) 14(5): NP doi:10.1093/neuonc/nos040

  • Subscription Page

    Neuro Oncol (2012) 14(5): NP doi:10.1093/neuonc/nos050

  • Contents Page

    Neuro Oncol (2012) 14(5): NP doi:10.1093/neuonc/nos020

Editorial

Review

    • Joachim M. Baehring and
    • Peter W. Marks

    Treatment-related myelodysplasia in patients with primary brain tumors

    Neuro Oncol (2012) 14(5): 529-540 first published online March 29, 2012 doi:10.1093/neuonc/nos068

Case Study

    • Giselle Sarganas,
    • Hans D. Orzechowski,
    • Andreas Klimpel,
    • Michael Thomae,
    • Wolfgang Kauffmann,
    • Hermann Herbst,
    • Elisabeth Bronder,
    • and Edeltraut Garbe

    Severe sustained cholestatic hepatitis following temozolomide in a patient with glioblastoma multiforme: case study and review of data from the FDA adverse event reporting system

    Neuro Oncol (2012) 14(5): 541-546 first published online March 6, 2012 doi:10.1093/neuonc/nos056

Basic and Translational Investigation

    • Amanda M. Saratsis,
    • Sridevi Yadavilli,
    • Suresh Magge,
    • Brian R. Rood,
    • Jennifer Perez,
    • D. Ashley Hill,
    • Eugene Hwang,
    • Lindsay Kilburn,
    • Roger J. Packer,
    • and Javad Nazarian

    Insights into pediatric diffuse intrinsic pontine glioma through proteomic analysis of cerebrospinal fluid

    Neuro Oncol (2012) 14(5): 547-560 first published online April 5, 2012 doi:10.1093/neuonc/nos067
    • Harpreet Kaur,
    • Susan M. Burden-Gulley,
    • Polly J. Phillips-Mason,
    • James P. Basilion,
    • Andrew E. Sloan,
    • and Susann M. Brady-Kalnay

    Protein tyrosine phosphatase mu regulates glioblastoma cell growth and survival in vivo

    Neuro Oncol (2012) 14(5): 561-573 first published online April 14, 2012 doi:10.1093/neuonc/nos066
    • Xiumei Zhao,
    • Zhigang Liu,
    • Litian Yu,
    • Yujing Zhang,
    • Patricia Baxter,
    • Horatiu Voicu,
    • Sivashankarappa Gurusiddappa,
    • Joseph Luan,
    • Jack M. Su,
    • Hon-chiu Eastwood Leung,
    • and Xiao-Nan Li

    Global gene expression profiling confirms the molecular fidelity of primary tumor-based orthotopic xenograft mouse models of medulloblastoma

    Neuro Oncol (2012) 14(5): 574-583 first published online March 29, 2012 doi:10.1093/neuonc/nos061
    • Courtney A. Crane,
    • Brian J. Ahn,
    • Seunggu J. Han,
    • and Andrew T. Parsa

    Soluble factors secreted by glioblastoma cell lines facilitate recruitment, survival, and expansion of regulatory T cells: implications for immunotherapy

    Neuro Oncol (2012) 14(5): 584-595 first published online March 9, 2012 doi:10.1093/neuonc/nos014
    • Immacolata Andolfo,
    • Lucia Liguori,
    • Pasqualino De Antonellis,
    • Emilio Cusanelli,
    • Federica Marinaro,
    • Francesca Pistollato,
    • Livia Garzia,
    • Gennaro De Vita,
    • Giuseppe Petrosino,
    • Benedetta Accordi,
    • Roberta Migliorati,
    • Giuseppe Basso,
    • Achille Iolascon,
    • Giuseppe Cinalli,
    • and Massimo Zollo

    The micro-RNA 199b-5p regulatory circuit involves Hes1, CD15, and epigenetic modifications in medulloblastoma

    Neuro Oncol (2012) 14(5): 596-612 first published online March 12, 2012 doi:10.1093/neuonc/nos002
    • Elana S. Tykocinski,
    • Ryan A. Grant,
    • Gurpreet S. Kapoor,
    • Jaroslaw Krejza,
    • Leif-Erik Bohman,
    • Timothy A. Gocke,
    • Sanjeev Chawla,
    • Casey H. Halpern,
    • Joanna Lopinto,
    • Elias R. Melhem,
    • and Donald M. O'Rourke

    Use of magnetic perfusion-weighted imaging to determine epidermal growth factor receptor variant III expression in glioblastoma

    Neuro Oncol (2012) 14(5): 613-623 first published online April 4, 2012 doi:10.1093/neuonc/nos073

Clinical Investigations

    • Tony W. Wilson,
    • Elizabeth Heinrichs-Graham,
    • and Michele R. Aizenberg

    Potential role for magnetoencephalography in distinguishing low- and high-grade gliomas: a preliminary study with histopathological confirmation

    Neuro Oncol (2012) 14(5): 624-630 first published online March 23, 2012 doi:10.1093/neuonc/nos064
    • Julio C. Furlan,
    • Kelvin K.-W. Chan,
    • Guillermo A. Sandoval,
    • Kenneth C. K. Lam,
    • Christopher A. Klinger,
    • Roy A. Patchell,
    • Audrey Laporte,
    • and Michael G. Fehlings

    The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost-utility analysis

    Neuro Oncol (2012) 14(5): 631-640 first published online April 14, 2012 doi:10.1093/neuonc/nos062
    • Matthew Crocker,
    • Samira Saadoun,
    • Alexa Jury,
    • Chris Jones,
    • Stergios Zacharoulis,
    • Samiwel Thomas,
    • Reyer Zwiggelaar,
    • Leslie R. Bridges,
    • B. Anthony Bell,
    • and Marios C. Papadopoulos

    Glioblastoma blood flow measured with stable xenon CT indicates tumor necrosis, vascularity, and brain invasion

    Neuro Oncol (2012) 14(5): 641-648 first published online April 5, 2012 doi:10.1093/neuonc/nos063
    • Cécile Colavolpe,
    • Olivier Chinot,
    • Philippe Metellus,
    • Julien Mancini,
    • Maryline Barrie,
    • Céline Bequet-Boucard,
    • Emeline Tabouret,
    • Olivier Mundler,
    • Dominique Figarella-Branger,
    • and Eric Guedj

    FDG-PET predicts survival in recurrent high-grade gliomas treated with bevacizumab and irinotecan

    Neuro Oncol (2012) 14(5): 649-657 first published online February 29, 2012 doi:10.1093/neuonc/nos012
    • Hanna van Alkemade,
    • Michelle de Leau,
    • Edith M.T. Dieleman,
    • Jan W.P.F. Kardaun,
    • Rob van Os,
    • W. Peter Vandertop,
    • Wouter R. van Furth,
    • and Lukas J.A. Stalpers

    Impaired survival and long-term neurological problems in benign meningioma

    Neuro Oncol (2012) 14(5): 658-666 first published online March 9, 2012 doi:10.1093/neuonc/nos013
    • Jaime Gállego Pérez-Larraya,
    • Marion Lahutte,
    • Gregorio Petrirena,
    • Germán Reyes-Botero,
    • Alberto González-Aguilar,
    • Caroline Houillier,
    • Rémy Guillevin,
    • Marc Sanson,
    • Khê Hoang-Xuan,
    • and Jean-Yves Delattre

    Response assessment in recurrent glioblastoma treated with irinotecan-bevacizumab: comparative analysis of the Macdonald, RECIST, RANO, and RECIST + F criteria

    Neuro Oncol (2012) 14(5): 667-673 first published online April 4, 2012 doi:10.1093/neuonc/nos070

News and Announcements

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

« Previous | Next »

This Issue

May 2012 14 (5)
Neuro-Oncology
  1. Cover/Standing Material
  2. Editorial
  3. Review
  4. Case Study
  5. Basic and Translational Investigation
  6. Clinical Investigations
  7. News and Announcements

Find articles in this issue containing these words:

Advance Access
May 1, 2012

Current Issue

  1. May 2012 14 (5)
  1. Neuro-Oncology
  1. Alert me to new issues

Most